Je. Crusesawyer et al., THE PHOTODYNAMIC RESPONSE OF 2 RODENT TUMOR-MODELS TO 4 ZINC(II)-SUBSTITUTED PHTHALOCYANINES, British Journal of Cancer, 77(6), 1998, pp. 965-972
Four novel zinc (II)-substituted phthalocyanines, varying in charge an
d hydrophobicity, were evaluated in vivo as new photosensitizers for p
hotodynamic therapy. Two rat tumours with differing vascularity were u
sed: a mammary carcinoma (LMC1) and a fibrosarcoma (LSBD1), with vascu
lar components six times higher in the latter (10.8% +/- 1.5) than in
the former (1.8% +/- 1.4). Each sensitizer was assessed for tumour res
ponse relative to normal tissue damage, and optimum doses were selecte
d for further study, ranging from 0.5 to 20 mg kg(-1). Interstitial il
lumination of the rumours was carried out using a 200-mu m-core optica
l fibre with a 0.5 cm length of diffusing tip, at either 680 or 692 nm
, depending on the sensitizer. Light doses of between 200 and 600 J we
re delivered at a rate of 100 mW from the 0.5-cm diffusing section of
the fibre. Maximum mean growth delays ranged from 9 to 13.5 days depen
ding on sensitizer and type of tumour, with the most potent photosensi
tizer appearing to be the cationic compound. Histopathological changes
were investigated after treatment to determine the mechanism by which
tumour necrosis was effected. The tumours had the appearance of an in
farct and, under the conditions used, the observed damage was shown to
be mainly due to ischaemic processes, although some direct tumour cel
l damage could not be ruled out.